Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GermanVasc/MDEpiNet Paclitaxel Study

NCT04683458 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT04683458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04683458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GermanVasc/MDEpiNet Paclitaxel Study
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2021
Completion date
February 28, 2021
Enrollment
14,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

outcome, fatal, paclitaxel adverse reaction